JPH01197488A - Physiologically active substance ksb-1939 compound and production thereof - Google Patents

Physiologically active substance ksb-1939 compound and production thereof

Info

Publication number
JPH01197488A
JPH01197488A JP2254388A JP2254388A JPH01197488A JP H01197488 A JPH01197488 A JP H01197488A JP 2254388 A JP2254388 A JP 2254388A JP 2254388 A JP2254388 A JP 2254388A JP H01197488 A JPH01197488 A JP H01197488A
Authority
JP
Japan
Prior art keywords
ksb
compound
substance
active substance
physiologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2254388A
Other languages
Japanese (ja)
Inventor
Hideki Kato
秀樹 加藤
Reisuke Kobayashi
小林 ▲れい▼右
Hotoku Shimazu
嶋津 朋徳
Akinori Suzuki
鈴木 昭憲
Akira Isogai
磯貝 彰
Osamu Tada
修 多田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kumiai Chemical Industry Co Ltd
Original Assignee
Kumiai Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumiai Chemical Industry Co Ltd filed Critical Kumiai Chemical Industry Co Ltd
Priority to JP2254388A priority Critical patent/JPH01197488A/en
Priority to EP88110715A priority patent/EP0298423A3/en
Priority to AU18698/88A priority patent/AU615921B2/en
Priority to BR8803371A priority patent/BR8803371A/en
Priority to CN88104219A priority patent/CN1030790A/en
Priority to KR1019880008427A priority patent/KR890002163A/en
Priority to US07/216,128 priority patent/US4939166A/en
Publication of JPH01197488A publication Critical patent/JPH01197488A/en
Priority to US07/512,126 priority patent/US5091311A/en
Pending legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound, expressed by the formula and having the following physico-chemical properties. Color of substance; colorless. Elementary analysis (%); C, 69.38; H, 8.13; O, 22.50. Molecular formula; C37H52O9. Molecular weight; 640 [fast atom bombardment mass spectrometry (FABMS)]. Color reaction; positive to iodine, sulfuric acid reactions, etc., on silica gel thin layers and negative to ninhydrin, anisaldehyde and ferric chloride reactions. Solubility; insoluble in water and soluble in methanol, acetone, ethyl acetate, chloroform and hexane. Neutral, etc. USE:An insecticide, acaricide and anthelmintic agent. PREPARATION:A microorganism [e.g., Streptomyces.hygroscopicus KSB-1939 (FERM BP-1901)], belonging to the genus Streptomyces and capable of producing KSB-1939S5 compound is cultivated at 26-30 deg.C for 5-10 days, preferably by a submerged tank culture method.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は殺虫、殺ダニ、駆虫作用を示す新規生理活性物
質KSB−1939S、及びその製造法に関するもので
ある。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel physiologically active substance KSB-1939S exhibiting insecticidal, acaricidal and anthelmintic effects, and a method for producing the same.

(従来の技術) 農業用薬剤は、高い収穫を安定的に確保する上で必要不
可欠なものであることは言及の余地のないことであるが
、作物及び土壌への残留を通して人体に体する毒性や環
境汚染の問題等を引き起こす可能性も否定出来ず、更に
安全性の高い農業用薬剤の開発が望まれている1本発明
者らは、より安全なQ業を開発すべく、微生物生産物に
着目して研究を行なった。
(Prior art) It goes without saying that agricultural chemicals are indispensable for stably securing high yields, but they are toxic to humans through their residue in crops and soil. The possibility of causing environmental pollution problems cannot be denied, and the development of even safer agricultural chemicals is desired.1 In order to develop safer Q-products, the inventors of the present invention The research focused on.

これまでに微生物を起源とする殺虫性物質には、糸状菌
の生産する環状ペプチドであるデストルキシン〔アグリ
カルチュラル・アンド・バイオロジカル・ケミストリイ
(AHricultural  and  Biolo
gical  Chemistry)  第26巻、 
第36頁(1962年)〕、バチルス屈細菌の生産する
結晶性蛋白質であるデルタ−エンドトキシン〔a業と園
芸第47巻。
So far, insecticidal substances originating from microorganisms include destruxin, a cyclic peptide produced by filamentous fungi [AHricultural and Biolo
(Gical Chemistry) Volume 26,
36 (1962)], delta-endotoxin, a crystalline protein produced by Bacillus bacteria [A-Kyo to Horiku Vol. 47.

第11号、第1507頁(1972年)〕、放線菌の生
産するピロン系のピエリシジン〔アグリカルチュラル・
アンド・バイオロジカル・ケミストリイ第30巻、第5
17頁(1966年)〕、ピロリドンを母核とする電子
伝達11fl害物質マクロテトロライド群にはいるテト
ラナクチン〔ジャーナル・アンチバイオチフス(Jou
rr+nl Antibiotlcs)第24A巻、第
418頁(1971年)〕1本発明化合物に橘造が類似
したマクロライド系のミルベマイシン〔ザ・ジャーナル
・オン・アンチバイオチフス(Tha Journal
 of Antibiotics)第29巻、第76頁
(1976年〕〕、アバメクチン類〔アンチミクロバイ
アル・エイジェンツ・アンド・ケモゼラビイ(Anti
sicrobial Agents and Cham
otharpy)第15巻、j@361頁(1’J79
年))、LL−F28249α〔ジャーナル゛オンケミ
カル°ソサイアテイ・ケミカル・コミニュケーション(
Journal of Cha廁1cal 5ocie
ty Cha會1calCo++wun1cat1on
)第402頁(1987年)〕が知られている。
No. 11, p. 1507 (1972)], pyrone series piericidin produced by actinomycetes [Agricultural
and Biological Chemistry Volume 30, No. 5
17 (1966)], tetranactin, which belongs to the macrotetrolide group of electron transport 11fl harmful substances with pyrrolidone as the mother nucleus [Journal Antibiotic Fever (Jou
rr+nl Antibiotlcs) Volume 24A, Page 418 (1971)] 1 Milbemycin, a macrolide similar to the compound of the present invention by Tachibana [The Journal on Antibiotyphoid Fever (The Journal
of Antibiotics, Volume 29, Page 76 (1976)], Abamectins [Antimicrobial Agents and Chemotherapy (1976)]
ciclobial agents and cham
otharpy) Volume 15, j@361 pages (1'J79
)), LL-F28249α [Journal on Chemical Society Chemical Communication (
Journal of Cha 1cal 5ocie
ty Chakai1calCo++wun1cat1on
), page 402 (1987)] is known.

(発明が解決しようとするm1ll) 本発明は、新規な天然生理活性物質を提供することを目
的とする。
(M1ll to be Solved by the Invention) An object of the present invention is to provide a novel natural physiologically active substance.

(課題を解決するための手段) 本発明者らは、新規な微生物生産生理活性物質の探索を
目的に種々の土壌から菌株を分離し、その生産する代謝
産物について研究を続けた結果、土壌より新たに分離し
たKSB−1939株の培養物中に強力な殺虫、殺ダニ
及び駆虫作用を示す活性物質が生産されることを見い出
し、その生理活性物質を単層、採取することに成功した
(Means for Solving the Problems) The present inventors isolated bacterial strains from various soils for the purpose of searching for novel physiologically active substances produced by microorganisms, and as a result of continuing research on the metabolites produced by the strains, they found that We discovered that an active substance exhibiting strong insecticidal, acaricidal, and anthelmintic effects was produced in a culture of the newly isolated KSB-1939 strain, and succeeded in collecting a monolayer of the physiologically active substance.

すなわち1本発明の生理活性物質は 式 にて示される。That is, one physiologically active substance of the present invention is formula It is shown in

本発明の生理活性物質をKSB−1939S、と称する
The physiologically active substance of the present invention is referred to as KSB-1939S.

本発明のKSB−1939S、は、下記の理化学的性質
を有する。
KSB-1939S of the present invention has the following physical and chemical properties.

■物質の色 :無色 ■元素分析値:C:69.38% If  8.13% 0:22.50% ■分子式  : Cs t Hs x O−■分子量 
 : 640 (FABMS)■紫外線吸収スペクトル
:第1図に示す。
■Color of substance: Colorless ■Elemental analysis value: C: 69.38% If 8.13% 0:22.50% ■Molecular formula: Cs t Hs x O- ■Molecular weight
: 640 (FABMS) ■Ultraviolet absorption spectrum: Shown in FIG.

■赤外線吸収スペクトル:第2図に示す。■Infrared absorption spectrum: Shown in Figure 2.

■核磁気共鳴スペクトル:第3図に示す。■Nuclear magnetic resonance spectrum: Shown in Figure 3.

■呈色反応 ニジリカゲル簿層上で ヨウ素反応 +、硫酸反応 +、ニンヒドリン反応 −
■Color reaction Iodine reaction +, sulfuric acid reaction +, ninhydrin reaction - on the Nijirica gel layer
.

アニスアルデヒド反応 −9塩化化第銑鉄応 −52,
4−ジニトロフェニルヒドラジン反応 十■溶解性  
:水に不溶、メタノール、アセトン、酢酸エチル、クロ
ロホルム、ヘキサンに可溶。
Anisaldehyde reaction -9 Pig iron chloride reaction -52,
4-dinitrophenylhydrazine reaction
: Insoluble in water, soluble in methanol, acetone, ethyl acetate, chloroform, hexane.

[相]塩基性、a性、中性の区分:中性法にKSB−1
939S、の構造解析について説明する。
[Phase] Basic, a-based, neutral classification: KSB-1 for neutral method
The structural analysis of 939S will be explained.

実施例に従って得られたKSB−1939S、の理化学
的性質、特に紫外線吸収スペクトル、プロトン及びカー
ボン核磁気共鳴スペクトルの解析から、この物質は16
員マクロライド系物質であり1gt量分析データ(E’
I及びFAB)で確Uされた分子量640に該当する既
知のマクロライド物質はなくその新規性が推察できた。
From the analysis of the physical and chemical properties of KSB-1939S obtained according to the examples, especially the ultraviolet absorption spectrum, proton and carbon nuclear magnetic resonance spectra, this substance is 16
It is a member macrolide substance, and the 1gt amount analysis data (E'
There is no known macrolide substance that corresponds to the molecular weight of 640 determined by I and FAB), and its novelty can be inferred.

本発明化合物と悶造的に近縁と考えられるミルベマイシ
ン類、アバメクチン類、LL−F28249α等は、何
れもストレプトミセスに屑する放線菌の生産する殺虫性
マクロライドと称する物質であり、これらの構造解析に
関して、ミルベマイシンについては、アブストラクト・
ベーバーズ(Abastract papers)第3
09〜316頁〔第18回シンポジウム・ケミカル・ナ
チュラル・プロダクツ・キヨウト(Syvposiun
 Chamlcal Natural Product
s+ Kyoto)  (1974年10月17〜19
日開催)〕及びテトラヒドロン・レターズ(Tatra
hedron Latters)第711−714頁(
1975年)に、アバメクチンレこついて、はジャーナ
ル・オン・アメリカン・ケミカル・ソサIティ(Jou
rnal of AmericanChamical 
5oeiaty)第1036.第4216−4221頁
(1981年)に、また、LL−F28249について
は、前述の文献に記載されている。
Milbemycins, abamectins, LL-F28249α, etc., which are thought to be closely related to the compounds of the present invention, are all substances called insecticidal macrolides produced by actinomycetes that are common to Streptomyces. Regarding analysis, for milbemycin, abstract
Babers (Abstract papers) No. 3
Pages 09-316 [18th Symposium Chemical Natural Products Kiyoto (Syvposiun)
Chamlcal Natural Product
s+ Kyoto) (October 17-19, 1974)
)] and Tetrahydrone Letters (Tatra
hedron latters) pages 711-714 (
In 1975), Abamectin was used in the Journal of the American Chemical Society.
rnal of american chemical
5oeiaty) No. 1036. 4216-4221 (1981), and LL-F28249 is described in the above-mentioned literature.

本発明のKSB−19395,の諸データを、これら文
献に示された構造解析データを参考にして検討した結果
The results of examining the various data of KSB-19395 of the present invention with reference to the structural analysis data shown in these documents.

■基本骨格は、ザ・ジャーナル・オン・アンチバイオチ
フス第33巻、第1121頁(1980年)に記載のラ
クトン環をもった前述の式(1)で示されるものである
こと、■マクロライド環の13位には、アバメクチンに
みられる糖側鎖が存在しないこと。
■The basic skeleton is one shown by the above formula (1) with a lactone ring as described in The Journal on Antibiotics, Volume 33, Page 1121 (1980), ■Macrolide There is no sugar side chain found in abamectin at the 13th position of the ring.

■スビラ環上の24位にメチル基及び25位にエチル基
を有していること、 ■KSB−1939S5の特徴は54位の炭素につなが
る側鎖にあり、マクロライド環4位の炭素に3−メチル
−2=ブテノイルオキシメチル基が連結していること、
が解析でき、前述の式(1)で示される新規物質と決定
した。
■KSB-1939S5 has a methyl group at the 24th position and an ethyl group at the 25th position on the subira ring. ■The characteristics of KSB-1939S5 are the side chain connected to the 54th carbon, and the 3rd carbon at the 4th position of the macrolide ring. -Methyl-2=butenoyloxymethyl group is connected,
could be analyzed and determined to be a new substance represented by the above-mentioned formula (1).

本発明のKSB−1939s、の生産菌の一例としては
An example of a producing strain of KSB-1939s of the present invention is:

本発明者らによって和歌山系新宮市街の土壌から分離さ
れた放線菌KSB−1939株がある。KSB−193
9株の菌学的性質は1次の通りである。
There is an actinomycete KSB-1939 strain that was isolated from the soil of Shingu City in the Wakayama region by the present inventors. KSB-193
The mycological properties of the nine strains are as follows.

本菌株の同定は1国際ストレプトミセス計画(I S 
P)の方法とワックスマン氏の方法により、その記載は
ISPの例に準じて行なった。
The identification of this strain was carried out by the International Streptomyces Project (IS).
The description was made according to the example of ISP using the method of P) and Mr. Waxman's method.

(1)形態的性質 双生菌糸は、分岐しながら生長し、菌糸の分断は、観察
されない、気中菌糸は、グルコース・アスパラギン寒天
培地、オートミール寒天培地等で旺盛に着生し胞子形成
も良好である。気中菌糸は1分岐しながら空中に伸長し
短い主軸又は分枝上に胞子鎖を車軸分岐する。胞子鎖は
2通常コイル状螺旋を呈する。長期間培養すると、胞子
鎖先端が黒粘貿塊化し。
(1) Morphological properties Twin hyphae grow while branching, and hyphal division is not observed.Aerial hyphae adhere vigorously on glucose-asparagine agar medium, oatmeal agar medium, etc., and have good sporulation. be. Aerial hyphae extend into the air while branching, and the spore chains are branched onto short main axes or branches. The spore chains exhibit two usually coiled helices. When cultured for a long period of time, the tip of the spore chain turns into a black clay mass.

更に進んだ部分は、気中菌糸全体が黒褐色粘質塊化する
(グルコース・アスパラギン寒天培地、オートミール寒
天培地)。
In further advanced areas, the entire aerial mycelium becomes a blackish-brown sticky mass (glucose-asparagine agar medium, oatmeal agar medium).

胞子鎖の幅は20.5ないし0.8ミクロン、胞子表面
は、シワ状(Varty)を呈し胞子の区切りが不鮮明
なため、詳しい個々の胞子の形状及び連結数は、不明で
あるが10胞子以上の連結が詔められる。また胞子は、
運動性を示さず、胞子嚢、菌核等は、IIl祭されない
The width of the spore chain is 20.5 to 0.8 microns, and the spore surface is wrinkled and the divisions between the spores are unclear, so the detailed shape of each spore and the number of connections are unknown, but there are about 10 spores. The above connections are recommended. Also, the spores are
Sporangia, sclerotia, etc. are not motile and are not cultivated.

(2)ジアミノピメリン酸分析 全菌体加水分解物のLL−ジアミノピメリン酸が認めら
れ細胞壁タイプI型である。
(2) Diaminopimelic acid analysis LL-diaminopimelic acid was observed in the whole bacterial cell hydrolyzate, indicating cell wall type I.

(3)各種培地における生育状態 培養3A間目の生育状態は、第1表に示す通りである。(3) Growth status in various media The growth status of the 3A period of culture is as shown in Table 1.

(4)生理的性質 ■生育温度範囲      20〜40℃最適温度範囲
      25〜35℃■ゼラチンの液化     
十 ■R粉の加水分解     十 ■脱脂牛乳の凝固     十 ペプトン化       十 ■メラニン様色素の生成 チロシン寒天培地          −ペプトン・イ
ースト・鉄寒天培地   −トリプトン・イースト・ブ
ロス    −■硝酸塩の還元           
 十(5)各炭素源の同化性 (プリドハム・ゴドリーブ寒天培地上)L−アラビノー
ス、D−キシロース、D−グルコース、D−フラクトー
ス、シュクロース、L−ラムノース、ラフィノース、D
−マンニトール、L−イノシトールの全ての炭素源を同
化する。
(4) Physiological properties ■ Growth temperature range 20-40℃ Optimum temperature range 25-35℃ ■ Liquefaction of gelatin
10 ■ Hydrolysis of R flour 10 ■ Coagulation of skim milk 10 Peptonization 10 ■ Production of melanin-like pigment Tyrosine agar medium - Peptone yeast iron agar medium - Tryptone yeast broth - ■ Reduction of nitrates
(5) Assimilation of each carbon source (on Pridham-Godelieve agar medium) L-arabinose, D-xylose, D-glucose, D-fructose, sucrose, L-rhamnose, raffinose, D
-Assimilates all carbon sources of mannitol, L-inositol.

上記の菌学的性質をインターナショナル・ジャーナル・
オン・システマチック・バクテリオロジー(■nter
nationalJournal of Systim
atic Bacteriolgy)第22巻、第30
7〜311頁(1972年)の記載を参照し同定を行っ
た結果。
The above mycological properties were published in the International Journal
On Systematic Bacteriology (■nter
National Journal of System
atic Bacteriology) Volume 22, No. 30
Results of identification with reference to the description on pages 7-311 (1972).

KSB−4939株は、シュクロース、ラフィノースの
同化の点で僅かに差を詔めるものの、基本性状(形態及
び各種培地での生育状態)がストレプトミセス・バイグ
ロスコピカス(Streptomyces hygro
scoplcus)  とよく一致することから。
Although there are slight differences in the assimilation of sucrose and raffinose, the KSB-4939 strain has basic properties (morphology and growth status on various media) that are similar to Streptomyces hygroscopicus.
scoplcus).

ストレプトミセス・バイグロスコピカス KSB−19
39と命名しf:、KS[3−1939株は、Ha相和
62年6月2日付で微工研菌寄第9436号(FERM
P−9436)として寄託されている。尚、KSB−1
939株は、他の放線菌の場合にみられるように、その
性状が変化しやすい0例えば、KS[3−,1939株
又はこの株に出来する突然変異株(自然発生又は誘発性
)、形質融合体又は遺伝子組換え体であっても、KSn
−1939株にその形質起源を依存しKSB−193O
S、を生産するものは総て本発明に使用出来る。
Streptomyces vigroscopicus KSB-19
39, f:, KS [3-1939 strain was published in Ha-Aiwa on June 2, 1962, as published in FERM
P-9436). Furthermore, KSB-1
The 939 strain is susceptible to changes in its properties, as seen in the case of other actinomycetes. Even if it is a fusion or genetically recombinant, KSn
KSB-193O depends on the -1939 strain for its trait origin.
All those that produce S can be used in the present invention.

また1本発明の製造法は、KSB−1939株の培養と
培養物からの生理活性物質のJll+出、希製からなる
The production method of the present invention comprises culturing the KSB-1939 strain, extracting and diluting a physiologically active substance from the culture.

すなわち、培養に当ってKSB−1939株を通常の微
生物が利用しうろ栄養物を含有する培地で培養する。栄
養源としては、従来放線菌の培養に利用されている公知
のものが使用できろ6例えば、炭素源として、グルコー
ス、グリセリン、マルトース、ラクトース、水&+、デ
キストリン、澱粉、動植物油等を使用できる。またg素
源としては、ビースト、大豆粉、/JX麦胚芽、コーン
ステイープリカー、落花生粉、綿実粉。
That is, during culturing, strain KSB-1939 is cultured in a medium containing nutrients used by ordinary microorganisms. As the nutrient source, known ones that have been conventionally used for culturing actinomycetes can be used.6 For example, as the carbon source, glucose, glycerin, maltose, lactose, water &+, dextrin, starch, animal and vegetable oils, etc. can be used. . In addition, the g sources include beast, soybean flour, /JX wheat germ, cornstarch liquor, peanut flour, and cottonseed flour.

ペプトン、肉エキス、酵母エキス、硫酸アンモニウム、
硝酸ソーダ、9素等が使用できる。その他、必要に応じ
て、ナトリウム、カリウム、カルシウム、マグネシウム
、コバルト。
Peptone, meat extract, yeast extract, ammonium sulfate,
Sodium nitrate, 9 elements, etc. can be used. In addition, sodium, potassium, calcium, magnesium, and cobalt as required.

塩!+1AM、硫酸及びその他のイオンを生成すること
が出来る無機塩類を添加することも有効である。また菌
の発育を助け、KSB−1939S、の生産を促進する
ような有機物及び無機物を適男に添加することも出来る
salt! It is also effective to add inorganic salts capable of producing +1 AM, sulfuric acid and other ions. It is also possible to add organic and inorganic substances to the mixture that aid the growth of bacteria and promote the production of KSB-1939S.

培養法としては、好気的条件下での培養法、特に深部タ
ンク培養法が最も適している。培養に適当な温度は、1
5〜37℃であるが、多くの場合、26〜30℃付近で
培養する。
The most suitable culture method is a culture method under aerobic conditions, especially a deep tank culture method. The appropriate temperature for culturing is 1
The temperature is 5 to 37°C, but in many cases it is cultured at around 26 to 30°C.

KSB−1939s、の生産は、培地や培養条件により
異なるが、浸透培養、タンク培養とも5〜10日の間で
その培養が最高に達する。
The production of KSB-1939s varies depending on the medium and culture conditions, but the culture reaches its maximum within 5 to 10 days in both infiltration culture and tank culture.

このようにして生産されたKSB−1939S、はその
理化学的性質に従って培養物から抽出、精製することが
可能であるが、特に以下の方法により効率的に抽出、精
製出来る。
KSB-1939S produced in this manner can be extracted and purified from the culture according to its physicochemical properties, and in particular can be efficiently extracted and purified by the following method.

すなわち、KSB−19395sの大部分は培養菌体中
に生産されるので、培養物は濾過又は遠心分離によって
菌体を分離し、菌体を分離し、菌体をアセトン又はアル
コールで抽出し、抽出液を減圧濃縮後、酢酸エチル、ク
ロロホルムのような転溶性溶剤に転溶させるか、いきな
り培養物又は濃縮液を前述のような転溶性溶剤にて抽出
する。転溶液を濃縮乾燥させるとKSB−19395,
を含む粉末又は油状の粗製品を得ることが出来る。
That is, since most of KSB-19395s is produced in cultured bacterial cells, the cultured cells are separated by filtration or centrifugation, the bacterial cells are separated, and the bacterial cells are extracted with acetone or alcohol. After concentrating the liquid under reduced pressure, it is dissolved in a transferable solvent such as ethyl acetate or chloroform, or the culture or concentrate is immediately extracted with a transferable solvent such as those described above. When the inverted solution is concentrated and dried, KSB-19395,
It is possible to obtain a powder or oily crude product containing.

粗製品は、KSB−1939S、を含む複数の殺虫性I
!1#物質の混合物として得られるため、脂溶性物質の
精製に通常用いられる公知の方法1例えばシリカゲル、
アルミナ等の担体を用いたカラムクロマトグラフィーに
より分画精製することが必要である。このクロマトグラ
フィーの条件の選択により本発明のKSB−1939S
5を高収率でかつ高純度で得ることが出来るが、更に、
純化界を採取する場合には、精製品のMy!J又は逆層
カラムを用いた高速液体クロマトグラフィーによる分画
が有効である。この他にゲル濾過法、吸着剤を用いた分
画法、結晶化等の方法の採用も可能である。
The crude product contains several insecticidal compounds, including KSB-1939S,
! 1 # Known methods commonly used for purification of fat-soluble substances because they are obtained as a mixture of substances 1 For example, silica gel,
It is necessary to carry out fractional purification by column chromatography using a carrier such as alumina. By selecting these chromatography conditions, the KSB-1939S of the present invention
5 can be obtained in high yield and high purity, but furthermore,
When collecting purified world, use the purified product My! Fractionation by high performance liquid chromatography using a J or reverse phase column is effective. In addition, it is also possible to employ methods such as gel filtration, fractionation using an adsorbent, and crystallization.

次に、実施例を挙げて具体的に説明するが本物質の製造
法はこれに限定されるものではない。
Next, the present substance will be specifically explained with reference to examples, but the method for producing this substance is not limited thereto.

実施例 I KSB−1939株の継代スラントからその1片を、麦
芽エキス1.0%、酵母エキス0.4%、グルコース0
.4%。
Example I One piece from the subculture slant of KSB-1939 strain was treated with 1.0% malt extract, 0.4% yeast extract, and 0 glucose.
.. 4%.

脱脂大豆0.2%の組成からなる種培養培地100mQ
を入れた500mA三角フラスコに移し、振どう培養機
にて、28℃で3日1111種培養を行った1次にli
t粉3%、酵母エキス0゜5%、コーンスチーブリ力−
0.5%、燐酸二カリウム0.2%、硫酸マグネシュウ
ム0.05%、プロナール502(12逍:東邦化学工
業株式会社)0.05%の組成からなる2゜Qの生産用
培地をジャーファーメンタ−に入れ、滅菌冷却後、11
M述の種培養液を接種し、通気量2012/毎分1、培
養温度28℃1回転数150回転/毎分の条件にて9日
間培養を行った。培養終了後、セライトを助剤として吸
引濾過を行い、菌体を集めた。a菌体を10Qのアセト
ンに分散させ、1時間撹拌して抽出を行った後、濾過に
より清澄なアセトン液を回収した1次いで減圧濃縮にて
アセトンを除去し、水200maにて残留物を洗い集め
た後、酢酸エチル500mQにて2回転溶抽出を行った
。酢酸エチル転溶成約1αに無水硫酸ナトリウム50g
を加えて脱水し、減圧濃縮して酢酸エチルを外し油状物
質的6gを回収した。クロロホルム95重量部に重量5
部のアセトンを加えた展開液少量に油状物質を溶解し。
Seed culture medium 100mQ consisting of 0.2% defatted soybean
1111 seeds were cultured for 3 days at 28°C in a shaking incubator.
T-flour 3%, yeast extract 0.5%, cornstarchy
A 2°Q production medium consisting of 0.5% dipotassium phosphate, 0.2% magnesium sulfate, 0.05% magnesium sulfate, and 0.05% Pronal 502 (12th grade: Toho Chemical Industry Co., Ltd.) was used in Jafar. Place in a mentor, sterilize and cool, then
The seed culture solution described in M was inoculated and cultured for 9 days under the conditions of an aeration rate of 2012/min, a culture temperature of 28°C, and a rotation speed of 150 revolutions/min. After the culture was completed, the cells were collected by suction filtration using Celite as an auxiliary agent. Disperse the bacterial cells in 10Q acetone, stir for 1 hour for extraction, and collect the clear acetone solution by filtration.1 Next, remove the acetone by vacuum concentration, and wash the residue with 200mA of water. After collection, elution extraction was performed twice with 500 mQ of ethyl acetate. 50g of anhydrous sodium sulfate to about 1α of ethyl acetate
was added to remove the ethyl acetate and concentrated under reduced pressure to recover 6 g of oily substance. 95 parts by weight of chloroform and 5 parts by weight
Dissolve the oily substance in a small amount of developing solution with acetone added.

内径50mm、高さ650mmのカラムを用いてシリカ
ゲルクロマトグラフィーを行った。2Omjlずつに分
取したフラクションの活性画分を集め、減圧乾燥を行う
ことによりKSB−19395,の22%を含有する混
合粗精製粉末90mgを採取した。
Silica gel chromatography was performed using a column with an inner diameter of 50 mm and a height of 650 mm. The active fractions were collected in 20 mjl fractions and dried under reduced pressure to obtain 90 mg of mixed crude powder containing 22% of KSB-19395.

実施例 2 実施例 1に記載した粗製品50mgを2mfiのアセ
トニトリルに溶解し、内径20mm、長さ250mmの
ODSカラムをセットした分取用高速液体クロマトグラ
フィーに注入した。80%アセトニトリル10m11/
毎分を溶出液として流し、240mmの紫外部吸収によ
り検出してKSB−1939S、の活性画分を採取し1
分画液を濃縮乾固することにより純度65%のKSB−
1939S5含有物15mgを得た。更に、内径20m
m、長さ250mmのシリカゲルカラムをセットし九分
取用液体クロマトグラフィーにKSB−1939S、の
65%含有物をヘキサン1mjlに溶解注入しヘキサン
及びイソプロピルアルコールの混合液(98:2)で展
開してKSB−19395,画分を集め減圧乾燥するこ
とにより純化界8.5mgを採取した。
Example 2 50 mg of the crude product described in Example 1 was dissolved in 2 mfi acetonitrile and injected into a preparative high performance liquid chromatography equipped with an ODS column with an inner diameter of 20 mm and a length of 250 mm. 80% acetonitrile 10ml/
The active fraction of KSB-1939S was collected every minute as an eluent and detected by ultraviolet absorption at 240 mm.
By concentrating the fraction to dryness, KSB-
15 mg of 1939S5-containing material was obtained. Furthermore, the inner diameter is 20m
A silica gel column with a length of 250 mm was set and a 65% content of KSB-1939S was dissolved in 1 mjl of hexane and injected into a preparative liquid chromatography system, and developed with a mixture of hexane and isopropyl alcohol (98:2). KSB-19395 was collected, and the fractions were collected and dried under reduced pressure to obtain 8.5 mg of purified product.

以下余白 本発明化合物を殺虫殺ダニ剤として使用するには1本発
明化合物それ自体で用いてもよいが、通常は担体、界面
活性剤、分散剤又は補助剤等を配合して常法により、粉
剤、水和剤。
To use the compound of the present invention as an insecticide and acaricide, the compound of the present invention may be used by itself, but it is usually mixed with a carrier, a surfactant, a dispersant, or an auxiliary agent, etc., and then used in a conventional manner. Powders, hydrating agents.

乳剤、微粒剤又は粒剤等に製剤して使用する。担体とし
ては。
It is used in formulations such as emulsions, microgranules, or granules. As a carrier.

タルク、ベントナイト、クレー、カオリン、珪藻土、ホ
ワイトカーボン、バーミュライト、消石灰、珪砂、m安
、尿素等の固体担体及びトルエン、メチルエチルケトン
、メチルナフタリン、イソプロピルアルコール、キシレ
ン、シクロヘキサノン等の散体担体が挙げられる。界面
活性剤及び分散剤としては1例えば、ジナフチルメタン
ジスルホン酸塩、アルコール硫酸エステル塩、アルキル
アリールスルホン酸塩、リグニンスルホン酸塩、ポリオ
キシエチレングリコールエーテル。
Solid carriers such as talc, bentonite, clay, kaolin, diatomaceous earth, white carbon, vermulite, slaked lime, silica sand, ammonium, urea, etc., and powder carriers such as toluene, methyl ethyl ketone, methyl naphthalene, isopropyl alcohol, xylene, cyclohexanone, etc. It will be done. Examples of surfactants and dispersants include dinaphthylmethane disulfonate, alcohol sulfate ester salt, alkylaryl sulfonate, lignin sulfonate, and polyoxyethylene glycol ether.

ポリオキシエチレンアルキルアリールエーテル、ポリオ
キシエチレンソルビタンモノアルキレート等が挙げられ
る。補助剤としてカルボキシメチルセルロース、ポリエ
チレングリコール、アラビアゴム等が挙げられる。これ
らの製剤は、適宜な一度に希釈して散布するか、又はi
i!接施用する。
Examples include polyoxyethylene alkylaryl ether and polyoxyethylene sorbitan monoalkylate. Examples of adjuvants include carboxymethylcellulose, polyethylene glycol, gum arabic, and the like. These preparations can be diluted and applied at any suitable time, or i.
i! apply.

次に本発明の製剤例を挙げて具体的に説明する。下記製
剤例中の%は1重量百分率を示す。
Next, the present invention will be specifically explained with reference to formulation examples. % in the following formulation examples indicates 1 weight percentage.

製剤例1 粉 剤 KSB−19395,0,5%、珪藻土5%及びクレー
94゜5%を均一に混合し粉砕して粉剤とした。
Formulation Example 1 Powder KSB-19395, 0.5%, diatomaceous earth 5% and clay 94.5% were uniformly mixed and pulverized to obtain a powder.

製剤例2 水和剤 KSB−19393,2%、珪藻±53%、クレー40
%、ジナフチルメタンジスルホン醜ナトリウム2%及び
リグニンスルホン酸ナトリウム3%を均一に混合し粉砕
して水和剤とした。
Formulation example 2 Wettable powder KSB-19393, 2%, diatom ±53%, clay 40
%, 2% sodium dinaphthylmethanedisulfonate, and 3% sodium ligninsulfonate were uniformly mixed and pulverized to prepare a wettable powder.

製剤例3 乳 剤 KSB−1939S、5%、キシレン30%、ポリオキ
シエチレンアルキルアリールエーテル11%、アルキル
ベンゼンスルホン酸カルシウム4%及びメチルナフタリ
ン50%を均一に溶解して乳剤とした。
Formulation Example 3 Emulsion An emulsion was prepared by uniformly dissolving 5% KSB-1939S, 30% xylene, 11% polyoxyethylene alkylaryl ether, 4% calcium alkylbenzenesulfonate, and 50% methylnaphthalene.

製剤例4 粒 剤 KSB−1939S50,5%、ラウリルアルコール硫
酸エステルのナトリウム塩2%、リグニンスルホン酸ナ
トリウム5%、カルボキシメチルセルロース %を均一に混合粉砕する.この混合物100重量部に水
20重量部を加えて練合し、押出式造粒機を用いて14
〜32メツシユの粒状に加工したのち、乾燥して粒剤と
した。
Formulation Example 4 Granules 50.5% of KSB-1939S, 2% of sodium salt of lauryl alcohol sulfate, 5% of sodium lignin sulfonate, and % of carboxymethyl cellulose are uniformly mixed and ground. Add 20 parts by weight of water to 100 parts by weight of this mixture, knead it, and use an extrusion type granulator for 14 parts by weight.
After processing into granules of ~32 meshes, they were dried to form granules.

(発明の効果) 本発明化合物は,農業用殺虫殺ダニ剤,殺虫性医薬品,
家畜・ペット用駆虫剤,防虫・防蟻剤,衛生m殺虫殺ダ
ニ剤として有用である.本発明化合物は,構造の類似し
た公知物質であるアパメクチンと比較しても優れた殺虫
活性を示すものである。
(Effects of the invention) The compounds of the present invention can be used as agricultural insecticides, acaricides, insecticidal pharmaceuticals,
It is useful as a dewormer for livestock and pets, an insect repellent/termite repellent, and a sanitary insecticide and acaricide. The compound of the present invention exhibits superior insecticidal activity compared to apamectin, a known substance with a similar structure.

次に本発明化合物の奏する効果を試験例を挙げて具体的
に説明する。
Next, the effects of the compounds of the present invention will be specifically explained using test examples.

試験例1 ナミハダニ殺成虫試験 径55mmのポリエチレン製カップに水を注ぎ、中心に
径10mmの穴を開けた蓋をし、蓋の穴から脱脂綿を垂
らして水を吸い上げるようにした後、蓋の上にろ紙をの
せ、その上にインゲンのリーフディスクを2枚置き,デ
ィスクに常に水が供給されるようにした.毛筆を用いて
リーフディスク当り10頭のナミハダニ雌成虫を接種し
,24時間後に異常虫を取り除き、製剤例2に準じて調
製した水和剤を所定1度に希釈し,薬液が2mg/am
’相当量となるように散布した。
Test example 1 Two-spotted spider mite adult insecticidal test Pour water into a polyethylene cup with a diameter of 55 mm, cover with a lid with a hole of 10 mm in diameter in the center, drop absorbent cotton from the hole in the lid to absorb the water, and place on the lid. A filter paper was placed on top of the filter paper, and two green bean leaf disks were placed on top of the filter paper to ensure that water was constantly supplied to the disks. Using a brush, 10 adult female two-spotted spider mites were inoculated per leaf disk, and after 24 hours, the abnormal insects were removed, and the wettable powder prepared according to Formulation Example 2 was diluted to a predetermined degree, so that the chemical solution was 2 mg/am.
'It was sprayed in a considerable amount.

試験は,2連にて行い,薬剤処理2日後に実体顕微鏡に
てダニの生死を判定し.下記の計算式により補正死出率
を算出した.尚、アバメクチンは.C−076−Bla
 (80%以上)及びC−076−Bib (20%以
下)の混合物を比較剤として供試した.結果を第2表に
示す。
The test was conducted in duplicate, and two days after the drug treatment, the survival of the mites was determined using a stereomicroscope. The corrected mortality rate was calculated using the formula below. Furthermore, abamectin is... C-076-Bla
(80% or more) and C-076-Bib (20% or less) was used as a comparison agent. The results are shown in Table 2.

試験例2 トビイロウンカ殺虫試験 製剤例2に準じて調製した水和剤を所定濃度に水で希釈
ル・これに稲茎葉を浸漬し風乾した後,試験管に入れた
.その中にトビイロウンカ幼虫1017j[を放ち,脱
脂綿で詮をして25℃の恒温にて5日間飼育した.試験
は,2連にで行い.飼育後の死出率を算出した.結果を
第3表に示す。
Test Example 2 Brown Planthopper Insecticide Test A wettable powder prepared according to Preparation Example 2 was diluted with water to a specified concentration. Rice stalks and leaves were immersed in this solution, air-dried, and then placed in a test tube. Brown planthopper larvae 1017j were released into the larvae, and the larvae were covered with absorbent cotton and kept at a constant temperature of 25°C for 5 days. The test was conducted in two series. The mortality rate after rearing was calculated. The results are shown in Table 3.

試験例3 ニカメイチュウ殺虫試験 製剤例2に準じてFIIIIした水和剤を所定濃度に水
で希釈し。
Test Example 3 A wettable powder prepared according to Preparation Example 2 was diluted with water to a predetermined concentration.

これに稲芽出し籾を浸漬し風乾した後,径55mmのポ
リエチレン製カップに入れた.その中にニカメイチュウ
3齢幼虫101?[を放ち、25℃の恒温にて5日間飼
育した.試験は、2連にて行い.飼育後の死出率を算出
した.結果を第4表に示す。
The sprouted paddy was soaked in this, air-dried, and then placed in a polyethylene cup with a diameter of 55 mm. Is there 101 3rd instar nymphs among them? [] and reared at a constant temperature of 25°C for 5 days. The test was conducted in two series. The mortality rate after rearing was calculated. The results are shown in Table 4.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は.KSB−1939S5の紫外線吸収スペクト
ルを、第2図は、KSB−19395,の赤外線吸収ス
ペクトルを,第3図は、KSB−1939S.のプロト
ン核磁気共鳴スペクトルを示す。
Figure 1 is. Figure 2 shows the ultraviolet absorption spectrum of KSB-1939S5, Figure 3 shows the infrared absorption spectrum of KSB-19395, and Figure 3 shows the infrared absorption spectrum of KSB-1939S. This shows the proton nuclear magnetic resonance spectrum of .

Claims (1)

【特許請求の範囲】 (1)式 ▲数式、化学式、表等があります▼ にて表されるKSB−1939S_5化合物。 (4)ストレプトミセス属に属するKSB−1939S
_5化合物の生産菌を培養し、培養物から当該化合物を
採取することを特徴とする当該化合物の製造法。
[Claims] (1) A KSB-1939S_5 compound represented by the formula ▲ Numerical formulas, chemical formulas, tables, etc. are available. (4) KSB-1939S belonging to the genus Streptomyces
_5 A method for producing a compound, which comprises culturing a producing bacterium and collecting the compound from the culture.
JP2254388A 1987-07-07 1988-02-02 Physiologically active substance ksb-1939 compound and production thereof Pending JPH01197488A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2254388A JPH01197488A (en) 1988-02-02 1988-02-02 Physiologically active substance ksb-1939 compound and production thereof
EP88110715A EP0298423A3 (en) 1987-07-07 1988-07-05 Antibiotic ksb-1939 compounds and production process thereof as well as pesticidal agents containing same
AU18698/88A AU615921B2 (en) 1987-07-07 1988-07-05 Antibiotic ksb-1939 compounds and production process thereof as well as pesticidal agents containing same
BR8803371A BR8803371A (en) 1987-07-07 1988-07-06 PESTICIDE COMPOUND, PROCESS FOR ITS PRODUCTION AND PESTICIDE AGENT
CN88104219A CN1030790A (en) 1987-07-07 1988-07-07 KSB-1939 compound, its method for making of antibiosis arranged and contain the sterilant of this compounds
KR1019880008427A KR890002163A (en) 1987-07-07 1988-07-07 Antimicrobial KSB-1939 compound and preparation method thereof and pesticide containing the same
US07/216,128 US4939166A (en) 1987-07-07 1988-07-07 Antibiotic KSB-1939 compounds as well as pesticidal agents containing same
US07/512,126 US5091311A (en) 1987-07-07 1990-04-17 The production of ksb-1939 macrolides using str eptomyces hygroscopicus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2254388A JPH01197488A (en) 1988-02-02 1988-02-02 Physiologically active substance ksb-1939 compound and production thereof

Publications (1)

Publication Number Publication Date
JPH01197488A true JPH01197488A (en) 1989-08-09

Family

ID=12085737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2254388A Pending JPH01197488A (en) 1987-07-07 1988-02-02 Physiologically active substance ksb-1939 compound and production thereof

Country Status (1)

Country Link
JP (1) JPH01197488A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008191A (en) * 1986-12-11 1991-04-16 Sankyo Company Limited Macrolide compounds, their preparation and their use
US5212322A (en) * 1986-12-11 1993-05-18 Sankyo Company, Limited Macrolide compounds, their preparation and their use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008191A (en) * 1986-12-11 1991-04-16 Sankyo Company Limited Macrolide compounds, their preparation and their use
US5212322A (en) * 1986-12-11 1993-05-18 Sankyo Company, Limited Macrolide compounds, their preparation and their use

Similar Documents

Publication Publication Date Title
KR940004098B1 (en) Process for the preparation of new antibiotics
EP0170006A2 (en) Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
US5051255A (en) Nematocidal preparations
US5747025A (en) Biological control of pests
FI94262C (en) Process for preparing macrolide against parasites
JP2865302B2 (en) 2-Pyranone derivative, method for producing the same, and antibacterial agent containing the same
US5091311A (en) The production of ksb-1939 macrolides using str eptomyces hygroscopicus
US3992551A (en) Antisiotic substances B-41, their production and their use as insecticides acaricides
US5317030A (en) Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
JPH01197488A (en) Physiologically active substance ksb-1939 compound and production thereof
JP2746372B2 (en) F-0368 substance
DD252116A5 (en) METHOD OF CONTROLLING PLANT NEMATODES
CA2013412A1 (en) Anthelmintic bioconversion products
JP4176077B2 (en) Novel FKI-1033 substance and production method thereof
US3992552A (en) Antibiotic substance B-41, their production and their use as insecticides and acaricides
JP3107326B2 (en) Physiologically active substances NK-04000P, NK-04000Q, methods for producing the same, and herbicides containing the same as an active ingredient
JP3902826B2 (en) Asperparaline, method for producing the same, and insecticide containing the same as an active ingredient
US2990330A (en) Streptomyces griseus strain 528 nrrl 2607 antibiotic and fermentation process
US5198464A (en) Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
JPH02121994A (en) Physiologically active substance ksb-1939l3 compound and production thereof
KR100327510B1 (en) Antifungal activity and Preparation-method of antibiotics produced from Micromonospora coerulea Ao58
US3992527A (en) Antibiotic substances B-41, their production and their use as insecticides and acaricides
US4730039A (en) Leucanicidin
JPH0398593A (en) Production of antibiotic 5'-o-sulfurmoyltubercidin and its use
US5275938A (en) Process for producing leucanicidin